… dedicated to examining how pharma executives and other leaders … telomerase inhibitor blood cancer treatment Rytelo. When it finally … PharmaVoice. But Geron soon learned that launching a promising treatment … for brevity and style. PHARMAVOICE: What has been …

… imetelstat clinical response rates and treatment-emergent cytopenias. Clinical Pipeline Completed … CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY SOURCE: Geron Corporation Copyright Business Wire 2025 …

… Who Suffered Losses In Geron (GERN) To Contact … long-term stockholder of Geron securities between February 28, … is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf … board of directors of Geron have breached their fiduciary …

… , 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial- … B.S. in Clinical Pharmacy from Ain Shams University … Senior Vice President of Global Pharmaceutical Operations & Early … efficacy results of RYTELO treatment cause its benefit-risk …

… may have developed bias in treatment assignment due to observable side … study was supported by Syros Pharmaceuticals Inc. Amy DeZern, MD, disclosed … , Bristol Myers Squibb, Novartis, Kura, Geron, Servier, Keros, and Shattuck Labs …

… , 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial … to continued employment with Geron through the applicable vesting … under the plan. About Geron Geron is a commercial-stage … European Union for the treatment of certain adult patients …

… stocks to buy right now. Geron Corporation (NASDAQ:GERN) reported … revenue in the quarter. Is Geron Corp. (GERN) the Best … reiterated a Buy rating on Geron Corporation (NASDAQ:GERN), keeping … .72% from current levels. Geron Corporation (NASDAQ:GERN) is a …

… reiterated its Buy rating for Geron Corporation (NASDAQ:GERN) with a price … highlighted the strong performance of Geron Corporation’s (NASDAQ:GERN) RYTELO  in … the new CEO of Geron Corporation (NASDAQ:GERN). Geron Corporation (NASDAQ:GERN) is a …

… , Chief Executive Officer of SpyGlass Pharma. “Her prior experience managing multinational … ., Lensar Inc. (NASDAQ: LNSR) and Geron Corporation, where she also serves as … Indiana University Bloomington. ABOUT SPYGLASS PHARMA The SpyGlass Drug Delivery Platform …

… The Portnoy Law Firm advises Geron Corporation (“Geron” or “the Company”) (NASDAQ: GERN … action on behalf of investors. Geron investors that lost money on … Defendants repeatedly expressed confidence in Geron’s ability to capitalize on …